Trade Sale

Exscientia scents Kinetic for acquisition
Dundee spinout Kinetic Discovery has been picked up by its peer Exscientia in a deal consolidating the equity of Frontier IP, which held stakes in both drug discovery companies.
Forescout successfully tracks SecurityMatters in $113m deal
Forescout Technologies has paid approximately $113m to acquire operational technology security provider and University of Twente spinout SecurityMatters.
Oracle catches DataFox
Stanford-StartX Fund has exited business intelligence software provider DataFox in an acquisition of undisclosed size by Oracle.
ZoneFox enters Fortinet perimeter
Fortinet has acquired Edinburgh Napier spinout ZoneFox for an undisclosed sum and will integrate the company’s machine learning technology into its own cybersecurity offering.
Big deal: Novartis picks up Endocyte for $2.1bn
Endocyte emerged out of Purdue University in 1996, completed an initial public offering in 2011 and has now agreed to an acquisition by Novartis worth $2.1bn.
NovoEd passes acquisition test
Occupational learning tool developer NovoEd, based on research at Stanford, has been bought by Devonshire Investors after raising $4.8m of series A capital in 2014.
Turnitin marks Gradescope for acquisition
UC Berkeley’s SkyDeck accelerator has secured an exit as schoolwork assessment technology developer Gradescope was acquired by Turnitin.
VitalSource exercises Acrobatiq acquisition
Educational content creation platform Acrobatiq spun out from Carnegie Mellon University in 2015 and had been backed by the university's Carnegie Innovations division.

Other News

Investcorp cultivates Softgarden
Softgarden, a spinout of Saarland University, has been acquired for Investcorp Technology Partners for an undisclosed sum.
10x engineers Epinomics acquisition
Epigenomics services provider Epinomics, co-founded by Stanford University faculty and alumni, has been bought by 10x Genomics in a transaction which enables StartX to exit.
Dexcom collects TypeZero
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
City National pays out for Exactuals acquisition
Financial services firm City National Bank has bought Stanford StartX-backed royalties payment platform Exactuals having led its series B round last year.

Editor's Picks

Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
Big deal: Roche derives MS treatment
Versant's unusual build-to-buy model has resulted in Roche acquiring a target for MS based on UCSF research and the venture firm launching a new spinout, Pipeline Therapeutics.
Tsinghua spreads $1.3bn buyout
Tsinghua University offers $1.3bn in a takeover bid of smartphone chipset manufacturer Spreadtrum.
test reg

Login